Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer
<p>CONSORT Diagram</p>
Tallennettuna:
| Päätekijä: | |
|---|---|
| Muut tekijät: | , , , , , , , , , , , , , , |
| Julkaistu: |
2025
|
| Aiheet: | |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
| _version_ | 1849927633254481920 |
|---|---|
| author | Aurelius Omlin (14971513) |
| author2 | Richard Cathomas (14971516) Gunhild von Amsberg (14971519) Christoph Reuter (14971522) Susan Feyerabend (14971525) Wolfgang Loidl (14971528) Martin Boegemann (14971531) Anja Lorch (14971534) Axel Heidenreich (14971537) Igor Tsaur (14971540) Julian Larcher-Senn (14971543) Stefan A.J. Buck (14971546) Ron H.J. Mathijssen (14971549) Ulrich Jaehde (14971552) Silke Gillessen (14971555) Markus Joerger (14971558) |
| author2_role | author author author author author author author author author author author author author author author |
| author_facet | Aurelius Omlin (14971513) Richard Cathomas (14971516) Gunhild von Amsberg (14971519) Christoph Reuter (14971522) Susan Feyerabend (14971525) Wolfgang Loidl (14971528) Martin Boegemann (14971531) Anja Lorch (14971534) Axel Heidenreich (14971537) Igor Tsaur (14971540) Julian Larcher-Senn (14971543) Stefan A.J. Buck (14971546) Ron H.J. Mathijssen (14971549) Ulrich Jaehde (14971552) Silke Gillessen (14971555) Markus Joerger (14971558) |
| author_role | author |
| dc.creator.none.fl_str_mv | Aurelius Omlin (14971513) Richard Cathomas (14971516) Gunhild von Amsberg (14971519) Christoph Reuter (14971522) Susan Feyerabend (14971525) Wolfgang Loidl (14971528) Martin Boegemann (14971531) Anja Lorch (14971534) Axel Heidenreich (14971537) Igor Tsaur (14971540) Julian Larcher-Senn (14971543) Stefan A.J. Buck (14971546) Ron H.J. Mathijssen (14971549) Ulrich Jaehde (14971552) Silke Gillessen (14971555) Markus Joerger (14971558) |
| dc.date.none.fl_str_mv | 2025-11-25T13:07:40Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30707603 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/figure/Supplementary_Figure_S1_from_Randomized_Phase_II_Cabazitaxel_Dose_Individualization_and_Neutropenia_Prevention_Trial_in_Patients_with_Metastatic_Castration-Resistant_Prostate_Cancer/30707603 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Therapeutic Research and Development Clinical Research and Trials Methods and Technology Chemotherapy Clinical-Stage Research Computational Methods Algorithms Genitourinary Cancers Prostate cancer Pharmacology Pharmacokinetics and pharmacodynamics |
| dc.title.none.fl_str_mv | Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer |
| dc.type.none.fl_str_mv | Image Figure info:eu-repo/semantics/publishedVersion image |
| description | <p>CONSORT Diagram</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_8acfb8d03fa47f32b1c51936ddb7573b |
| identifier_str_mv | 10.1158/1078-0432.30707603 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30707603 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate CancerAurelius Omlin (14971513)Richard Cathomas (14971516)Gunhild von Amsberg (14971519)Christoph Reuter (14971522)Susan Feyerabend (14971525)Wolfgang Loidl (14971528)Martin Boegemann (14971531)Anja Lorch (14971534)Axel Heidenreich (14971537)Igor Tsaur (14971540)Julian Larcher-Senn (14971543)Stefan A.J. Buck (14971546)Ron H.J. Mathijssen (14971549)Ulrich Jaehde (14971552)Silke Gillessen (14971555)Markus Joerger (14971558)CancerTherapeutic Research and DevelopmentClinical Research and TrialsMethods and TechnologyChemotherapyClinical-Stage ResearchComputational MethodsAlgorithmsGenitourinary CancersProstate cancerPharmacologyPharmacokinetics and pharmacodynamics<p>CONSORT Diagram</p>2025-11-25T13:07:40ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1158/1078-0432.30707603https://figshare.com/articles/figure/Supplementary_Figure_S1_from_Randomized_Phase_II_Cabazitaxel_Dose_Individualization_and_Neutropenia_Prevention_Trial_in_Patients_with_Metastatic_Castration-Resistant_Prostate_Cancer/30707603CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307076032025-11-25T13:07:40Z |
| spellingShingle | Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer Aurelius Omlin (14971513) Cancer Therapeutic Research and Development Clinical Research and Trials Methods and Technology Chemotherapy Clinical-Stage Research Computational Methods Algorithms Genitourinary Cancers Prostate cancer Pharmacology Pharmacokinetics and pharmacodynamics |
| status_str | publishedVersion |
| title | Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer |
| title_full | Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer |
| title_fullStr | Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer |
| title_full_unstemmed | Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer |
| title_short | Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer |
| title_sort | Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer |
| topic | Cancer Therapeutic Research and Development Clinical Research and Trials Methods and Technology Chemotherapy Clinical-Stage Research Computational Methods Algorithms Genitourinary Cancers Prostate cancer Pharmacology Pharmacokinetics and pharmacodynamics |